Artificial intelligence models: transforming early diagnosis and precise treatment of gastrointestinal cancers
Top Cited Papers
Open Access
- 2 March 2026
- journal article
- review article
- Published by Springer Nature in Molecular Cancer
- Vol. 25 (1)
Abstract
Artificial intelligence (AI) has become an integral force in the clinical landscape of gastrointestinal (GI) oncology. Recent advances in model architectures ranging from traditional machine learning and convolutional neural networks (CNNs) to transformer-based foundational models and graph neural networks (GNNs) have enabled the extraction of complex features from diverse data modalities, including endoscopic images, radiology, pathology whole-slide images, and multi-omics profiles. In this review, AI models are systematically classified into supervised learning, unsupervised clustering, multimodal fusion, and interpretable modeling. The advantages of each model are delineated in unravelling tumor heterogeneity, anatomical characteristics, and treatment-relevant biomarkers. Furthermore, three types of clinical application are emphasized: (1) early screening and lesion localization via segmentation or anomaly detection; (2) molecular subtyping and patient stratification for diagnosis with risk assessment; (3) therapy guidance through response prediction and personalized treatment planning. We also discuss major challenges on the application of AI in integration of heterogeneous clinical data, model generalizability across centers, and the interpretability of predictions. Collectively, this review highlights the transformative potential of AI in better understanding tumor biology and its clinical value in advancing personalized medicine for GI cancer patients.Keywords
Funding Information
- National Natural Science Foundation of China (32500508)
- National Natural Science Foundation of China (82203318)
- Science and Technology Innovation Key R&D Program of Chongqing (CSTB2024TIAD-KPX0028)
- Science and Technology Innovation Key R&D Program of Chongqing (CSTB2023TIAD-STX0002)
- National Key Research and Development Program of China (2023YFC3402100 and 2022YFA1105300)
- Natural Science Foundation of Chongqing Municipality (CSTB2023NSCQ-LZX0156)
- Natural Science Foundation of Chongqing Municipality (CSTB2022NSCQ-MSX0880)
- JinFeng Laboratory
This publication has 247 references indexed in Scilit:
- CRCFound: A Colorectal Cancer CT Image Foundation Model Based on Self‐Supervised LearningAdvanced Science, 2025
- Immunotyping the Tumor Microenvironment Reveals Molecular Heterogeneity for Personalized Immunotherapy in CancerAdvanced Science, 2025
- Interpretable Multimodal Fusion Model for Bridged Histology and Genomics Survival Prediction in Pan‐CancerAdvanced Science, 2025
- Multimodal Artificial Intelligence‐Based Virtual Biopsy for Diagnosing Abdominal Lavage Cytology‐Positive Gastric CancerAdvanced Science, 2025
- Bimodal In Situ Analyzer for Circular RNA in Extracellular Vesicles Combined with Machine Learning for Accurate Gastric Cancer DetectionAdvanced Science, 2025
- Artificial Intelligence for Predicting HER2 Status of Gastric Cancer Based on Whole‐Slide Histopathology Images: A Retrospective Multicenter StudyAdvanced Science, 2025
- Cancer situation in China: an analysis based on the global epidemiological data released in 2024Cancer Communications, 2024
- An Explainable Graph Neural Framework to Identify Cancer‐Associated Intratumoral Microbial CommunitiesAdvanced Science, 2024
- Assessment of Artificial Intelligence Chatbot Responses to Top Searched Queries About CancerJAMA Oncology, 2023
- Applied Logistic Regression2013